From the Analyst's Couch | Published:

The global landscape of cancer cell therapy

Nature Reviews Drug Discovery volume 17, pages 465466 (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

  1. Jun Tang, Vanessa M. Hubbard-Lucey, Jill O'Donnell-Tormey, Laura Pearce and Aiman Shalabi are at Cancer Research Institute, New York, NY, USA

    • Jun Tang
    • , Vanessa M. Hubbard-Lucey
    • , Laura Pearce
    • , Jill O'Donnell-Tormey
    •  & Aiman Shalabi

Authors

  1. Search for Jun Tang in:

  2. Search for Vanessa M. Hubbard-Lucey in:

  3. Search for Laura Pearce in:

  4. Search for Jill O'Donnell-Tormey in:

  5. Search for Aiman Shalabi in:

Competing interests

L.P. and A.S. are not employees but consultants to Cancer Research Institute. All other authors declare no competing interests.

Corresponding author

Correspondence to Jun Tang.

Supplementary information

PDF files

  1. 1.

    Supplementary Figure 1

    Numbers of different types of cell therapies in development.

  2. 2.

    Supplementary Figure 2

    The number of different types of cell therapies in development per country.

  3. 3.

    Supplementary Figure 3

    The contribution of academic institutes to cancer cell therapy development.

  4. 4.

    Supplementary Table

    The list of trials that combine cell therapies with anti-PD1/L1 agents.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrd.2018.74

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing